Search

Your search keyword '"McLendon, Roger E"' showing total 191 results

Search Constraints

Start Over You searched for: Author "McLendon, Roger E" Remove constraint Author: "McLendon, Roger E" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
191 results on '"McLendon, Roger E"'

Search Results

1. Failure of human rhombic lip differentiation underlies medulloblastoma formation

2. Aligning the Central Brain Tumor Registry of the United States (CBTRUS) histology groupings with current definitions.

3. Subgroup and subtype-specific outcomes in adult medulloblastoma

4. Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation

5. Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy

6. The transcriptional landscape of Shh medulloblastoma

7. Spatial transcriptomics reveals segregation of tumor cell states in glioblastoma and marked immunosuppression within the perinecrotic niche.

8. Repurposing Clemastine to Target Glioblastoma Cell Stemness

9. Supplementary Table 2 from Mutant IDH1 Disrupts the Mouse Subventricular Zone and Alters Brain Tumor Progression

10. Supplementary Table 3 from Mutant IDH1 Disrupts the Mouse Subventricular Zone and Alters Brain Tumor Progression

14. Supplementary Figures 1 through 5 from Mutant IDH1 Disrupts the Mouse Subventricular Zone and Alters Brain Tumor Progression

15. Data from Mutant IDH1 Disrupts the Mouse Subventricular Zone and Alters Brain Tumor Progression

20. Supplementary Materials and Methods from Mutant IDH1 Disrupts the Mouse Subventricular Zone and Alters Brain Tumor Progression

24. Supplementary Table 1 from Mutant IDH1 Disrupts the Mouse Subventricular Zone and Alters Brain Tumor Progression

25. Supplementary Figure Legends from A Modified Nucleoside 6-Thio-2′-Deoxyguanosine Exhibits Antitumor Activity in Gliomas

26. Supplementary fig 2 from A Modified Nucleoside 6-Thio-2′-Deoxyguanosine Exhibits Antitumor Activity in Gliomas

27. Supplementary Table S2 from Cic Loss Promotes Gliomagenesis via Aberrant Neural Stem Cell Proliferation and Differentiation

28. Supplementary Figure 7 from Differential Immune Microenvironments and Response to Immune Checkpoint Blockade among Molecular Subtypes of Murine Medulloblastoma

29. Figure S4 from A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo

30. Data from Cic Loss Promotes Gliomagenesis via Aberrant Neural Stem Cell Proliferation and Differentiation

31. Supplementary Data from Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination

32. Supplementary fig 6 from A Modified Nucleoside 6-Thio-2′-Deoxyguanosine Exhibits Antitumor Activity in Gliomas

33. Data from Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma

34. Supplementary fig 4 from A Modified Nucleoside 6-Thio-2′-Deoxyguanosine Exhibits Antitumor Activity in Gliomas

35. Figure S1_S2 from Cic Loss Promotes Gliomagenesis via Aberrant Neural Stem Cell Proliferation and Differentiation

36. Supplementary Tables from A Modified Nucleoside 6-Thio-2′-Deoxyguanosine Exhibits Antitumor Activity in Gliomas

37. Table S2 from A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma

38. Supplementary fig 3 from A Modified Nucleoside 6-Thio-2′-Deoxyguanosine Exhibits Antitumor Activity in Gliomas

39. Table S2 from Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma

40. Supplementary Figure 5 from Differential Immune Microenvironments and Response to Immune Checkpoint Blockade among Molecular Subtypes of Murine Medulloblastoma

41. Data from A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo

42. Data from Adaptive Evolution of the GDH2 Allosteric Domain Promotes Gliomagenesis by Resolving IDH1R132H-Induced Metabolic Liabilities

43. Figure S3 to S5 from Cic Loss Promotes Gliomagenesis via Aberrant Neural Stem Cell Proliferation and Differentiation

44. Supplemental Dataset A - IDH1-R132H effect on the metabolome. from Adaptive Evolution of the GDH2 Allosteric Domain Promotes Gliomagenesis by Resolving IDH1R132H-Induced Metabolic Liabilities

45. Supplementary Figure 4 from Differential Immune Microenvironments and Response to Immune Checkpoint Blockade among Molecular Subtypes of Murine Medulloblastoma

46. Supplementary Figures 1-9 from Construction of an Immunotoxin, D2C7-(scdsFv)-PE38KDEL, Targeting EGFRwt and EGFRvIII for Brain Tumor Therapy

47. Supplementary Table 1 and 2 from Differential Immune Microenvironments and Response to Immune Checkpoint Blockade among Molecular Subtypes of Murine Medulloblastoma

48. Supplementary fig 1 from A Modified Nucleoside 6-Thio-2′-Deoxyguanosine Exhibits Antitumor Activity in Gliomas

49. Supplementary Figure Legends from A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo

50. Figure Legend and Supplementary Figure 1 from Differential Immune Microenvironments and Response to Immune Checkpoint Blockade among Molecular Subtypes of Murine Medulloblastoma

Catalog

Books, media, physical & digital resources